All Markets served
/
UNITED STATES
/
FDA Medical Device Reporting (MDR) Consulting

FDA Medical Device Reporting (MDR) Consulting

If you manufacture or distribute medical devices in the US, you are legally required to comply with FDA Medical Device Reporting (MDR) under 21 CFR Part 803 (Subpart E) regardless of your device classification. FDA MDR activities include monitoring, identifying, and reporting serious device-related adverse events within strict timelines and documenting everything in your MDR files. Failure to fulfill FDA MDR obligations can expose your company to FDA warning letters, recalls, even enforcement, not to mention patient risk.

Subscribe to newsletter
Subscribe to receive our monthly newsletter to your inbox.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
US Market information

FDA MDR Reporting Requirements for Medical Device Manufacturers

Manufacturers, importers, and user facilities are mandatory reporters of medical device problems. However, the manufacturer is primarily responsible for reporting events involving their device to the FDA. “Medical Device Reporting for Manufacturers” outlines MDR obligations in detail, but here is an overview of key FDA MDR requirements:

What Triggers an FDA MDR Report

When manufacturers receive a complaint of a potential adverse event report, they must assess whether an event:

  • Resulted in death or serious injury (or may have contributed to that outcome), or
  • Involved a malfunction that could cause harm if it recurred

If there's uncertainty, the FDA expects manufacturers to err on the side of reporting.

Reporting Timeframes

Adverse events must be reported within 30 calendar days after becoming aware of the event or within 5 business days if the event requires prompt remedial action to protect public health or if FDA requests it.

What You Must Report

Manufacturers and importers are required to use the FDA’s Electronic Medical Device Reporting (eMDR) system to submit an adverse event report. Submissions route through the FDA’s Electronic Submissions Gateway (ESG), which securely receives and processes all electronic MDR files. Mandatory and voluntary MDR reports are publicly available in the MAUDE database.

Reports must include:

  • Complete patient and device information.
  • A clear narrative of what happened.
  • Details on outcomes, investigation, and corrective actions.
  • Any missing information (explain what isn’t available and why)

Submit supplemental MDRs within 30 days if new or corrected information arises. Make sure to reference the original MDR report number.

FDA MDR Record-Keeping Requirements as part of your QMS(R)

Under 21 CFR 803.18, manufacturers must establish and maintain written MDR procedures for identifying and evaluating adverse events, determining reportability, ensuring timely submission of MDRs, and maintaining MDR event files as part of your quality management system (QMS). MDR event files must document every adverse event, including your internal investigation notes, decisions on reportability, and all related correspondence. These files must contain copies of submitted MDR forms and electronic acknowledgments, and should link to relevant records like medical, engineering, or complaint files, testing or customer communication.

How We Can Help

Be Proactive about FDA MDR compliance

If your current MDR system is reactive, unreliable, or incomplete, you’re exposing your company and patients to harm and risking FDA action. Pure Global will build processes, train your team, and embed compliance into your product lifecycle to comply with FDA medical device reporting requirements. Contact us now for a gap assessment or to design an MDR system that meets FDA’s expectations and protects your business against risk.

Frequently
Asked Questions

Are any medical devices exempt from FDA Medical Device Reporting (MDR) requirements?

Manufacturers, importers, and user facilities can request an exemption, variance, or alternative reporting requirement. Exemptions are granted on a case-by-case basis and often apply to specific devices, adverse event types, or real-world data (RWD) sources like registries, electronic health records (EHRs), or claims databases. The FDA can impose specific conditions to maintain the exemption; exemptions can also be modified or revoked at any time.

What is VMSR summary reporting?

The Voluntary Malfunction Summary Reporting (VMSR) program allows manufacturers to report certain device malfunctions in summary form on a quarterly basis, instead of submitting individual Medical Device Reports (MDRs). To qualify, the device’s product code must be listed as eligible in the FDA’s Product Classification Database. Each summary report must include the total number of reportable malfunctions for each unique combination of brand name, model, and problem code. Importantly, individual MDRs are still required for events involving death or serious injury. Manufacturers must follow strict conditions outlined by the FDA, and noncompliance with VMSR requirements reverts the reporting obligation back to standard individual MDRs.

What are the FDA medical device reporting obligations for importers and user facilities?

Under 21 CFR Part 803, importers must report to both the FDA and the device manufacturer if they learn that a device may have caused or contributed to a death or serious injury. If the device malfunctioned in a way that could lead to these outcomes if it recurred, the importer must report it to the manufacturer only, not the FDA.

User facilities (e.g., hospitals and nursing homes) must report device-related deaths to both the FDA and the manufacturer. Serious injuries must be reported to the manufacturer, or to the FDA if the manufacturer is unknown. User facilities are not required to report device malfunctions, but they may do so voluntarily using FDA’s MedWatch Form 3500.

Will the new Quality Management System Regulation (QMSR) affect FDA MDR requirements?

No. The upcoming Quality Management System Regulation (QMSR), effective February 2026, harmonizes 21 CFR Part 820 with ISO 13485:2016. However, FDA has confirmed that 21 CFR Part 803 (MDR) will remain in force and unchanged. Manufacturers must continue to meet all MDR obligations under current law.

Single Process,
Multiple Markets

When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us